Skip to main content
. 2020 Jul 31;135(1 Suppl):172S–181S. doi: 10.1177/0033354920927845

Table 1.

Comparison of model implementation of US Preventive Services Task Force (USPSTF) recommendations and risk scenarios from the California Tuberculosis Risk Assessment Toola

Characteristics Baseline USPSTF
Recommendations
California Tuberculosis Risk Assessment Tool
General population 2% probability of testing per year 2% probability of testing per year 2% probability of testing per year
Non–US-born persons Not applicable Tested once Tested once
Health care workers Annual testing Annual testing Annual testing
Contacts of tuberculosis case Tested once, at time of contact investigation Tested once, at time of contact investigation Tested once, at time of contact investigation
Immunosuppressedb
 HIV positive Tested once Tested once Tested once
 TNF-α inhibitor use 85% tested once 85% tested once Tested once
 Transplant recipient Tested once Tested once Tested once
Current residents of HRCSs
 Long-term care facilities Tested on admission Tested annually Tested on admission
 Homeless shelters Not applicable Tested annually Not applicable
 Correctional facilities Tested on admission Tested annually Tested on admission
Former residents of HRCSs
 Long-term care facilities Not testedc Tested once Not testedc
 Homeless shelters Not testedc Tested once Not testedc
 Correctional facilities Not testedc Tested once Not testedc

Abbreviations: HRCS, high-risk congregate setting; TNF, tumor necrosis factor.

aModeled scenarios varied by the key populations prioritized for targeted tuberculosis testing and treatment and frequency of testing. Data sources: California Department of Public Health9 and USPSTF.12

bPersons with HIV undergo testing at the time of antiretroviral therapy initiation, which is used as a proxy for time of diagnosis. Persons who use TNF-α antagonists and recipients of solid-organ or bone marrow transplants undergo testing before initiation of immunosuppressive therapy or transplantation.

cNot tested refers to persons in this population not being tested an additional time in the model based on lack of a recommendation to do so in current guidelines or practice.